Marcelo Criscuolo
About
In The Last Decade
Marcelo Criscuolo
26 papers receiving 764 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 328
- Immunology 195
- Virology 178
- Surgery 128
- Cardiology and Cardiovascular Medicine 112
Countries citing papers authored by Marcelo Criscuolo
This map shows the geographic impact of Marcelo Criscuolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo Criscuolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo Criscuolo more than expected).
Fields of papers citing papers by Marcelo Criscuolo
This network shows the impact of papers produced by Marcelo Criscuolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo Criscuolo. The network helps show where Marcelo Criscuolo may publish in the future.
Co-authorship network of co-authors of Marcelo Criscuolo
This figure shows the co-authorship network connecting the top 25 collaborators of Marcelo Criscuolo. A scholar is included among the top collaborators of Marcelo Criscuolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcelo Criscuolo. Marcelo Criscuolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | Abstract 15235: High-Dose Plasmid VEGF Gene Transfer in Patients with Severe Coronary Artery Disease: Final Results of the First Latin American Trial of Gene Therapy in Myocardial Ischemia | 5 |
| 3 | 13 | |
| 4 | 15 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 23 | |
| 9 | 29 | |
| 10 | 8 | |
| 11 | 61 | |
| 12 | 33 | |
| 13 | 41 | |
| 14 | 53 | |
| 15 | 7 | |
| 16 | Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. | 62 |
| 17 | 7 | |
| 18 | 127 | |
| 19 | 75 | |
| 20 | 33 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.